Immunohistochemistry of lung tumors identified Gal-9 expression by NSCLC cells and TILs, correlation with TIM-3, PD-1, and PD-L1 expression, and poor patient prognosis [188]. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.